• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cureus . Systemic Capillary Leak Syndrome Induced by Influenza Type A Infection: A Case Report

tetano

Editor, Senior Moderator
Cureus


. 2023 Jan 25;15(1):e34213.
doi: 10.7759/cureus.34213. eCollection 2023 Jan.
Systemic Capillary Leak Syndrome Induced by Influenza Type A Infection: A Case Report


Masafumi Fukuda[SUP] 1 [/SUP], Masakazu Nabeta[SUP] 1 [/SUP], Nobuhisa Hirayu[SUP] 1 [/SUP], Mikinori Kannae[SUP] 1 [/SUP], Osamu Takasu[SUP] 1 [/SUP]



Affiliations

Abstract

Rhabdomyolysis accompanying influenza virus infection is a notable extrapulmonary complication. We experienced a case of influenza type A followed by rhabdomyolysis and systemic capillary leak syndrome (SCLS). A 57-year-old man with no significant past medical history was diagnosed as having influenza type A six hours after fever onset, and treatment with oseltamivir was started. Shock, rhabdomyolysis, and acute kidney injury (AKI) progressed rapidly. At 53 hours after starting the oral treatment, intensive care was initiated, including ventilation management. In the acute phase, a large-dose replacement was given for the SCLS and continuous renal replacement therapy for AKI; both eventually healed without sequelae.

Keywords: acute kidney injury; influenza virus type a; renal replacement therapy (rrt); rhabdomyolysis; systemic capillary leak syndrome.
 
Back
Top Bottom